Grandner, Michael
Olivieri, Antonio
Ahuja, Ajay
Büsser, Alexander
Freidank, Moritz
McCall, William V.
Funding for this research was provided by:
Idorsia Pharmaceuticals
Article History
Received: 15 February 2023
Accepted: 18 July 2023
First Online: 3 August 2023
Declarations
:
: Institutional review board approval was not deemed necessary for the conduct of this study. However, the protocol was consistent with the requirements of the Declaration of Helsinki due to the use of fully deidentified data.
: Not applicable.
: MG reports: institutional grants from Kemin Foods, CeraZ Technology, and Jazz Pharmaceuticals; consulting fees from Fitbit, Natrol, Merck, Idorsia Pharmaceuticals Ltd, Athleta, and Casper; expert witness testimony fees from Maricopa County; stock options with NightFood; consulting relationship with Idorsia Pharmaceuticals Ltd; and is president elect of the Society of Behavioral Sleep Medicine. WM reports being a scientific advisor for Idorsia Pharmaceuticals Ltd and a consultant for Carelon. AO, AA, and AB are employees of Idorsia Pharmaceuticals Ltd and/or Idorsia Pharmaceuticals US Inc. MF is an employee of Visium Ltd.